Rani Therapeutics Holdings, Inc.

About Rani Therapeutics Holdings, Inc.

Rani Therapeutics is a company focused on developing a disruptive technology for the oral delivery of biologics, including peptides, proteins, and antibodies. Their mission is to provide an alternative to painful injections for patients with chronic conditions, improving compliance and quality of life through their innovative RaniPill™ capsule.

Products & Services

RaniPill Platform:A technology capable of orally delivering biologics such as proteins, peptides, and antibodies, applicable across various therapeutic areas.

RT-111:An oral Ustekinumab biosimilar currently in Phase 1 clinical studies.

RT-102:A program with Phase 1 study results for repeat dose in osteoporosis treatment.

Specialties

Oral delivery of biologics Peptides, proteins, and antibodies delivery technology Clinical studies for biologics

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 60300000 MR: - FA: 60.3 million FAN: 60300000	D: 2025-10-23 FD: 2025-10-23	6 investors
2	RT: Private Placement T: - FT: Private Placement	A: 60300000 MR: - FA: 60.3 million FAN: 60300000	D: 2025-10-17 FD: 2025-10-17	6 investors
3	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 3000000 MR: - FA: 3.0 Million FAN: 3000000	D: 2025-07-15 FD: 2025-07-15	1 investors
4	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 10000000 MR: - FA: 10.0 million FAN: 10000000	D: 2024-10-15 FD: 2024-10-15	1 investors
5	RT: Registered Direct Offering T: - FT: Registered Direct Offering	A: 10000000 MR: - FA: 10.0 million FAN: 10000000	D: 2024-07-22 FD: 2024-07-22	1 investors

Private Placement Latest

2025-10-23

$60.3M

6 investors (Pro only)

Private Placement 2025-10-17

$60.3M

Registered Direct Offering 2025-07-15

$3.0M

View 4 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mir Imran

Founder and Executive Chairman

T

Talat Imran

Chief Innovator

M

Mir Hashim

Chief Innovator

S

Svai Sanford

Chief Financial Officer

K

Kate McKinley

Chief Business Officer

A

Alireza Javadi

VP of Technical Operations

View 12 more team members with Pro

Unlock Full Team Directory

Recent News